Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network.
Gandolfo P, Soeiro T, Jouve É, Revol B, Daveluy A, Bertin C, Eiden C, Gibaja V, Chaouachi L, Pérault-Pochat MC, Chevallier C, Aquizérate A, Le Boisselier R, Carton L, Lapeyre-Mestre M, Frauger É, Lacroix C, Micallef J. Gandolfo P, et al. Among authors: jouve e. Fundam Clin Pharmacol. 2024 Feb 19. doi: 10.1111/fcp.12995. Online ahead of print. Fundam Clin Pharmacol. 2024. PMID: 38372190
Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatment.
Houvenaeghel G, Cohen M, Gonçalves A, Berthelot A, Chauvet MP, Faure C, Classe JM, Jouve E, Sabiani L, Bannier M, Tassy L, Martino M, Tallet A, de Nonneville A. Houvenaeghel G, et al. Among authors: jouve e. Front Oncol. 2023 Dec 15;13:1287253. doi: 10.3389/fonc.2023.1287253. eCollection 2023. Front Oncol. 2023. PMID: 38162480 Free PMC article.
Negative Survival Impact of Occult Lymph Node Involvement in Small HER2-Positive Early Breast Cancer Treated by Up-Front Surgery.
Houvenaeghel G, Cohen M, Martino M, Reyal F, Classe JM, Chauvet MP, Colombo PE, Heinemann M, Jouve E, Gimbergues P, Azuar AS, Coutant C, Gonçalves A, de Nonneville A. Houvenaeghel G, et al. Among authors: jouve e. Cancers (Basel). 2023 Sep 14;15(18):4567. doi: 10.3390/cancers15184567. Cancers (Basel). 2023. PMID: 37760536 Free PMC article.
Is increased myocardial triglyceride content associated with early changes in left ventricular function? A 1H-MRS and MRI strain study.
Soghomonian A, Dutour A, Kachenoura N, Thuny F, Lasbleiz A, Ancel P, Cristofari R, Jouve E, Simeoni U, Kober F, Bernard M, Gaborit B. Soghomonian A, et al. Among authors: jouve e. Front Endocrinol (Lausanne). 2023 Jun 22;14:1181452. doi: 10.3389/fendo.2023.1181452. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37424866 Free PMC article.
Tocilizumab versus anakinra in COVID-19: results from propensity score matching.
Arcani R, Correard F, Suchon P, Kaplanski G, Jean R, Cauchois R, Leprince M, Arcani V, Seguier J, De Sainte Marie B, Andre B, Koubi M, Rossi P, Gayet S, Gobin N, Garrido V, Weiland J, Jouve E, Couderc AL, Villani P, Daumas A. Arcani R, et al. Among authors: jouve e. Front Immunol. 2023 May 26;14:1185716. doi: 10.3389/fimmu.2023.1185716. eCollection 2023. Front Immunol. 2023. PMID: 37304271 Free PMC article.
Erratum to 'Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes' [The Breast (2023) 102-109].
Glemarec G, Lacaze JL, Cabarrou B, Aziza R, Jouve E, Zerdoud S, De Maio E, Massabeau C, Loo M, Esteyrie V, Ung M, Dalenc F, Izar F, Chira C. Glemarec G, et al. Among authors: jouve e. Breast. 2023 Jun;69:424-427. doi: 10.1016/j.breast.2023.03.011. Epub 2023 May 10. Breast. 2023. PMID: 37172498 Free PMC article. No abstract available.
Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution.
Lacaze JL, Chira C, Glemarec G, Monselet N, Cassou-Mounat T, De Maio E, Jouve E, Massabeau C, Brac de la Perrière C, Selmes G, Ung M, Nicolai V, Cabarrou B, Dalenc F. Lacaze JL, et al. Among authors: jouve e. Breast Cancer Res Treat. 2023 Apr;198(3):463-474. doi: 10.1007/s10549-023-06880-9. Epub 2023 Feb 15. Breast Cancer Res Treat. 2023. PMID: 36790573
166 results